Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial

Kevin N. Sheth, Gregory W. Albers, Jeffrey L Saver, Bruce Campbell, Bradley J. Molyneaux, Holly E. Hinson, Charlotte Cordonnier, Thorsten Steiner, Kazunori Toyoda, Max Wintermark,

The Lancet Neurology · 2024 · 34 citations · 27 references

DOIFull text

Open access

Concepts

References

27